Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
DeepCure
DeepCure discovers and develops novel small-molecule therapies for immune and inflammatory diseases using AI to shorten the drug discovery timeline. The company operates a B2B SaaS-style drug…
DeepCure
DeepCure discovers and develops novel small-molecule therapies for immune and inflammatory diseases using AI to shorten the drug discovery timeline. The company operates a B2B SaaS-style drug…
TL;DR
What they do: AI-driven small-molecule discovery and development for immune and inflammatory diseases
Product: Integrated design-make-test-analyze (DMTA) platform (MolGen™, PocketExpander™, DiscoveryHub™) plus automated synthesis
Founded / HQ: 2018; Boston, MA
Recent financing: Series A announced Apr 11, 2024; reported total funding ≈ $71.4M (USD)
Team size: Approximately 31 employees
Company Overview
Problem Domain
Small-molecule drug discovery for immune and inflammatory diseases
Founded
2018
Industry
Biotechnology
Tech Stack
Funding Track Record
Series A announced Apr 11, 2024; multiple profiles report Series A activity
Multiple earlier rounds reported across public profiles
Investor Signal
“Benon Group Ltd.; Creative Destruction Lab (CDL); E14 Fund; IAG Capital Partners; Morningside; Sapir Venture Partners; TLV Partners”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,400+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |